cardiology

NHS England okays funding for cholesterol-lowering drug

https://pharmaphorum.com/news/nhs-england-okays-funding-for-cholesterol-lowering-drug-lojuxta/

Amgen’s Repatha gets EU cardio risk reduction label

https://pharmaphorum.com/news/amgens-repatha-gets-eu-cardio-risk-reduction-label/

EU approves AZ’s potential blockbuster hyperkalaemia drug

https://pharmaphorum.com/news/eu-approves-azs-potential-blockbuster-potassium-drug/

Double blow to Amgen with Sanofi’s Praluent data and price cut

https://pharmaphorum.com/news/sanofi-deals-double-blow-amgen-praluent-data-price-cut/

Digital health round-up: Could Nokia kill off digital health unit?

https://pharmaphorum.com/views-and-analysis/digital-health-round-nokia-kill-off-digital-health-unit/

AI predicts heart attack risk factors from retinal scans

https://pharmaphorum.com/news/ai-can-used-predict-heart-attack-risk-factors/

AI could save NHS billions in scan costs, says life sciences tsar

https://pharmaphorum.com/news/ai-save-nhs-billions-scan-costs-health-tsar/

FDA approves first smartphone compatible heart monitor

https://pharmaphorum.com/news/abbott-smartphone-heart-monitor-fda/

Merck axes cholesterol drug despite phase 3 success

https://pharmaphorum.com/news/merck-axes-cholesterol-drug-despite-phase-3-success/

1 2 3 4 5 >»

Close in 10 seconds

Pharmaphorum.com

Search